Literature DB >> 11873942

Localization of S100C immunoreactivity in various human tissues.

Asami Kondo1, Masakiyo Sakaguchi, Eiichi Makino, Masayoshi Namba, Shigeru Okada, Nam-ho Huh.   

Abstract

Using 2-dimensional gel electrophoresis, we previously demonstrated that the S100C protein remarkably decreased after immortalization of normal human fibroblasts, and that this protein caused growth inhibition of human tumor cells when forcibly expressed in these cells, suggesting that S100C plays a significant role in tumor suppression. The present study was carried out to determine what type of human tissues express S100C protein, and, subsequently, whether the S100C content in these tissues changes after normal cells have been transformed into cancer cells. We found that ductal cells in various tissues were positively stained with the S100C protein. In comparison, epithelial cells in digestive organs such as the stomach, small intestine, and colon were not stained as strongly. When 14 pairs of human normal and cancerous tissues were stained with the antibody, decreases in the staining levels of S100C were observed in 6 kinds of cancerous tissues--from the bronchus, mammary duct, renal tubule, prostate, uterus, and testis--in comparison with staining in their normal counterparts. These results suggest that S100C is a new tumor marker protein, the expression of which significantly decreases after malignant transformation of human tissues.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11873942     DOI: 10.18926/AMO/31719

Source DB:  PubMed          Journal:  Acta Med Okayama        ISSN: 0386-300X            Impact factor:   0.892


  11 in total

1.  Correlation between S100A11 and the TGF-β1/SMAD4 pathway and its effects on the proliferation and apoptosis of pancreatic cancer cell line PANC-1.

Authors:  Yi-Fei Ji; Tao Li; Feng Jiang; Wen-Kai Ni; Cheng-Qi Guan; Zhao-Xiu Liu; Cui-Hua Lu; Run-Zhou Ni; Wei Wu; Ming-Bing Xiao
Journal:  Mol Cell Biochem       Date:  2018-06-19       Impact factor: 3.396

2.  Alteration in protein expression in estrogen receptor alpha-negative human breast cancer tissues indicates a malignant and metastatic phenotype.

Authors:  Ziad J Sahab; Yan-Gao Man; Suzan M Semaan; Robert G Newcomer; Stephen W Byers; Qing-Xiang Amy Sang
Journal:  Clin Exp Metastasis       Date:  2010-07-03       Impact factor: 5.150

3.  Novel proteins regulated by mTOR in subependymal giant cell astrocytomas of patients with tuberous sclerosis complex and new therapeutic implications.

Authors:  Magdalena Ewa Tyburczy; Katarzyna Kotulska; Piotr Pokarowski; Jakub Mieczkowski; Joanna Kucharska; Wieslawa Grajkowska; Maciej Roszkowski; Sergiusz Jozwiak; Bozena Kaminska
Journal:  Am J Pathol       Date:  2010-02-04       Impact factor: 4.307

4.  Colorectal cancer progression correlates with upregulation of S100A11 expression in tumor tissues.

Authors:  Guiyu Wang; Xishan Wang; Shuhuai Wang; Hongtao Song; Haiming Sun; Weiguang Yuan; Bo Cao; Jing Bai; Songbin Fu
Journal:  Int J Colorectal Dis       Date:  2008-03-14       Impact factor: 2.571

Review 5.  Molecular Characteristics of RAGE and Advances in Small-Molecule Inhibitors.

Authors:  Hyeon Jin Kim; Mi Suk Jeong; Se Bok Jang
Journal:  Int J Mol Sci       Date:  2021-06-27       Impact factor: 5.923

Review 6.  Putative biomarkers and targets of estrogen receptor negative human breast cancer.

Authors:  Ziad J Sahab; Yan-Gao Man; Stephen W Byers; Qing-Xiang A Sang
Journal:  Int J Mol Sci       Date:  2011-07-13       Impact factor: 5.923

7.  Gene expression profile of adult human olfactory bulb and embryonic neural stem cell suggests distinct signaling pathways and epigenetic control.

Authors:  Hany E S Marei; Abd-Elmaksoud Ahmed; Fabrizio Michetti; Mario Pescatori; Roberto Pallini; Patricia Casalbore; Carlo Cenciarelli; Mohamed Elhadidy
Journal:  PLoS One       Date:  2012-04-02       Impact factor: 3.240

8.  Proteomic identification of secreted proteins as surrogate markers for signal transduction inhibitor activity.

Authors:  C M McClelland; W J Gullick
Journal:  Br J Cancer       Date:  2007-01-09       Impact factor: 7.640

Review 9.  Use of proteins as biomarkers and their role in carcinogenesis.

Authors:  Paul Zarogoulidis; Kosmas Tsakiridis; Chrisanthi Karapantzou; Sofia Lampaki; Ioannis Kioumis; Georgia Pitsiou; Antonis Papaiwannou; Wolfgang Hohenforst-Schmidt; Haidong Huang; George Kesisis; Ilias Karapantzos; Serafeim Chlapoutakis; Ippokratis Korantzis; Andreas Mpakas; Vasilis Karavasilis; Ioannis Mpoukovinas; Qiang Li; Konstantinos Zarogoulidis
Journal:  J Cancer       Date:  2015-01-01       Impact factor: 4.207

10.  Up-Regulation of S100A11 in Lung Adenocarcinoma - Its Potential Relationship with Cancer Progression.

Authors:  Tetsukan Woo; Koji Okudela; Hideaki Mitsui; Michihiko Tajiri; Yasushi Rino; Kenichi Ohashi; Munetaka Masuda
Journal:  PLoS One       Date:  2015-11-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.